Intravascular Ultrasound Evidence of Angiographically Silent Allograft Vasculopathy Inversely Correlates With Circulating Level of Hepatocyte Growth Factor

Journal of Heart and Lung Transplantation

Volumn 25, Issue 12, 2006, Pages 1456-1461

  Lee, Chii Ming ^a   Wu, Yen Wen ^a   Chou, Nai Kuan ^a   Jui, Hsiang Yiang ^a   Hsu, Ron Bin ^a   Wang, Shoei Shen ^a   Chen, Ming Fong ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; SCATTER FACTOR;

ADULT; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; INTRAVASCULAR ULTRASOUND; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LINEAR REGRESSION ANALYSIS; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VASCULAR ENDOTHELIUM;

ADULT; AGED; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; HEART TRANSPLANTATION; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 33845432449     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2006.09.018     Document Type: Article

References (25)

1. Kass M., and Haddad H. Cardiac allograft vasculopathy: pathology, prevention and treatment. Curr Opin Cardiol 21 (2006) 132-137
2. Mairesse G.H., Marwick T.H., Melin J.A., et al. Use of exercise electrocardiography, technetium-99m-MIBI perfusion tomography, and two-dimensional echocardiography for coronary disease surveillance in a low-prevalence population of heart transplant recipients. J Heart Lung Transplant 14 (1995) 222-229
3. Uretsky B.F., Murali S., Reddy P.S., et al. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 76 (1987) 827-834
4. Johnson D.E., Gao S.Z., Schroeder J.S., DeCampli W.M., and Billingham M.E. The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Transplant 8 (1989) 349-359
5. St Goar F.G., Pinto F.J., Alderman E.L., et al. Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of "angiographically silent" intimal thickening. Circulation 85 (1992) 979-987
6. Tuzcu E.M., Kapadia S.R., Sachar R., et al. Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. J Am Coll Cardiol (2005) 1538-1542
7. Kobashigawa J.A., Tobis J.M., Starling R.C., et al. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. J Am Coll Cardiol 45 (2005) 1532-1537
8. Hollenberg S.M., Klein L.W., Parrillo J.E., et al. Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death. Circulation 104 (2001) 3091-3096
9. Hollenberg S.M., Klein L.W., Parrillo J.E., et al. Changes in coronary endothelial function predict progression of allograft vasculopathy after heart transplantation. J Heart Lung Transplant 23 (2004) 265-271
10. El-Hamamsy I., Stevens L.M., Vanhoutte P.M., and Perrault L.P. Injury of the coronary endothelium at implantation increases endothelial dysfunction and intimal hyperplasia after heart transplantation. J Heart Lung Transplant 24 (2005) 251-258
11. Kawamoto R., Oka Y., Yoshida O., and Takagi Y. Significance of serum circulating hepatocyte growth factor in the development of carotid atherosclerosis. J Atheroscler Thromb 10 (2003) 154-159
12. Yoshitomi Y., Kojima S., Umemoto T., et al. Serum hepatocyte growth factor in patients with peripheral arterial occlusive disease. J Clin Endocrinol Metab 84 (1999) 2425-2428
13. Susen S., Sautiere K., Mouquet F., et al. Serum hepatocyte growth factor levels predict long-term clinical outcome after percutaneous coronary revascularization. Eur Heart J 26 (2005) 2387-2395
14. Ma H., Calderon T.M., Fallon J.T., and Berman J.W. Hepatocyte growth factor is a survival factor for endothelial cells and is expressed in human atherosclerotic plaques. Atherosclerosis 164 (2002) 79-87
15. Nakagami H., Morishita R., Yamamoto K., et al. Hepatocyte growth factor prevents endothelial cell death through inhibition of bax translocation from cytosol to mitochondrial membrane. Diabetes 51 (2002) 2604-2611
16. Nakagami H., Kaneda Y., Ogihara T., and Morishita R. Hepatocyte growth factor as potential cardiovascular therapy. Expert Rev Cardiovasc Ther 3 (2005) 513-519
17. Jayasankar V., Woo Y.J., Pirolli T.J., et al. Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure. J Card Surg 20 (2005) 93-101
18. Zwirska-Korczala K., Zakliczynski M., Berdowska A., Zembala M., Jochem J., and Gajewska K. Diagnostic validity of hepatocyte growth factor as marker for rejection in the follow-up of patients after heart transplantation. J Heart Lung Transplant (2005) 411-415
19. Yamaura K., Ito K., Tsukioka K., et al. Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy. Circulation 110 (2004) 1650-1657
20. Wu Y.W., Lee C.M., Lee Y.T., Wang S.S., and Huang P.J. Value of circulating adhesion molecules in assessing cardiac allograft vasculopathy. J Heart Lung Transplant 22 (2003) 1284-1287
21. Wu Y.W., Yen R.F., Lee C.M., et al. Diagnostic and prognostic value of dobutamine thallium-201 single-photon emission computed tomography after heart transplantation. J Heart Lung Transplant 24 (2005) 544-550
22. Pethig K., Heublein B., Meliss R.R., and Haverich A. Volumetric remodeling of the proximal left coronary artery: early versus late after heart transplantation. J Am Coll Cardiol 34 (1999) 197-203
23. Billingham M.E., Cary N.R., Hammond M.E., et al., The International Society for Heart Transplantation. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Transplant 9 (1990) 587-593
24. Hsu R.B., Chu S.H., Wang S.S., et al. Low incidence of transplant coronary artery disease in Chinese heart recipients. J Am Coll Cardiol 33 (1999) 1573-1577
25. Yasuda S., Goto Y., Baba T., et al. Enhanced secretion of cardiac hepatocyte growth factor from an infarct region is associated with less severe ventricular enlargement and improved cardiac function. J Am Coll Cardiol 36 (2000) 115-121